Congressional "Best Price" Proposals Could Eradicate "Authorized" Generic Firms
This article was originally published in The Pink Sheet Daily
Pfizer generic subsidiary head Kennally says provision in pending legislation "will likely be overturned."
You may also be interested in...
The study is expected to take roughly two years to complete, the Federal Trade Commission said.
The Energy & Commerce Committee proposal lacks increases in rebates paid by manufacturers but includes increases in beneficiary cost-sharing.
Chairman Grassley’s budget reconciliation proposal, which will be voted on by the committee on Oct. 24, also increases minimum manufacturer rebates paid to the Medicaid program.